Vulvovaginal atrophy: new and upcoming approaches.
Simon
James A
JA
D000042:Absorption; D000282:Administration, Intravaginal; D001284:Atrophy; D001943:Breast Neoplasms / Q000139:chemically induced; D004958:Estradiol / Q000008:administration & dosage / Q000493:pharmacokinetics; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004967:Estrogens / Q000008:administration & dosage / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D008593:Menopause; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage; D014621:Vagina / Q000378:metabolism / Q000473:pathology*; D014844:Vulva / Q000473:pathology*; D016387:Women's Health
D004967:Estrogens; D020845:Selective Estrogen Receptor Modulators; D004958:Estradiol